HIV/HCV Coinfected Children May Significantly Benefit From Early DAA Treatment
Children who are co-infected with HIV and hepatitis C virus may benefit from early treatment with direct acting antivirals
Hepatitis C
Conflict-Driven Migration Increases Hepatitis Burden as Production Costs Fall
Researchers of studies on the effect of conflict-driven migration on rates of hepatitis indicate that mass migration from high-burden countries has significantly increased the prevalence of both hepatitis C virus (HCV) and hepatitis B virus (HBV) infection in the host nation.
DAA Therapy Associated With Higher Survival in HCV-Related Comorbidities
Patients with hepatitis C virus (HCV) and comorbidities, including hepatocellular carcinoma (HCC), clinically significant portal hypertension, and cirrhosis were shown to have significantly higher survival rates when treatment included directly acting antiviral agent (DAA) therapy, according to the results of several studies presented at the American Association for the Study of Liver Diseases’ The Liver…
New EMR-Based Tools Improve Hepatitis Screening in Various Care Settings
New diagnostic tools used to identify hepatitis C virus (HCV) and hepatitis B virus (HBV) utilize simple questionnaires and emergency medical records (EMR) to alert physicians in both primary care and high-volume care settings about patients at risk for viral hepatitis infection or reactivation. The results of these studies were presented at the American Association…
Low Clinician Adherence Reported for Hepatitis C, HIV Guidelines
Clinician adherence to screening protocols for patients with hepatitis B (HBV), as well as to treatment guidelines for those with hepatitis C virus (HCV) is suboptimal.
Inverse Association Between Cannabis Use and Diabetes in Chronic HCV Infection
In a large cross-sectional study of patients with chronic hepatitis C virus (HCV) infection, cannabis use was inversely associated with diabetes.
Educational Intervention Improves HBV Care, More Needed for Underserved Populations With HCV
A patient-centered educational intervention for hepatitis B virus (HBV) infection can improve overall HBV care in underserved safety-net populations.
Direct-Acting Antivirals May Reduce Risk for Variceal Bleeding in Hepatitis C
Hepatitis C virus (HCV) sustained virologic response following direct-acting antiviral (DAA) therapy is associated with lower risk for variceal bleeding.
Increases in Hepatitis C Infection Rates Among Pregnant Opioid Users
The rate of hepatitis C virus infection (HCV) in pregnant women at the time of delivery in the US increased from 0.8 per 1000 live births in 2000 to 4.1 per 1000 in 2015.
Hepatitis C Virus Infection Rates Increased Among Women Giving Birth
Among women giving birth, the rates of HCV infection increased more than 400% from 2000 to 2015, with rates much higher among those with opioid use disorder.
Next post in Hepatitis
